Beacon Pointe Advisors, LLC
Position in BTAI — BioXcel Therapeutics, Inc.
CIK 1744317
NEWPORT BEACH, CA
Position in BTAI
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$25,295
-$8,814 QoQ
Shares Held
18,877
+0.2% QoQ
Ownership
0.061%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#17
of 40 holders
Holding Since
Mar 2025
3 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 0.ToString("F0")%
None 100.ToString("F0")%
Common Shares in BTAI Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026Beacon Pointe Advisors, LLC holds $6,694,336 across 7 Drug Manufacturers - Specialty & Generic names. BTAI ranks #7 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
29,753 | $3,517,102 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
|
2,417 | $1,433,232 | |
| 3 | TAK |
Takeda Pharmaceutical Co Ltd
|
32,930 | $609,863 | |
| 4 | HLN |
Haleon plc
|
48,499 | $485,474 | |
| 5 | VTRS |
Viatris Inc
|
27,557 | $372,295 | |
| 6 | AQST |
Aquestive Therapeutics, Inc.
|
60,500 | $251,075 | |
| 7 | BTAI |
BioXcel Therapeutics, Inc.
This page
|
18,877 | $25,295 |
All Filings in BTAI
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $25,295 | 18,877 | Shares | Sole | 2026-05-15 | |
| 2025-06-30 | $34,109 | 18,845 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $38,255 | 18,845 | Shares | Sole | 2025-05-13 | |
| No filing history on record for this holder in this stock. | ||||||